3 November 2020
In the fourth quarter of 2020, a new antibacterial drug under the trade name 3-Dinir has been launched in the Ukrainian market. This third generation oral cephalosporins containing the active substance cefdinir is new to the country.
Here you can find general information about the company intended for journalists and other stakeholders
For all media-related enquiries,
please contact us
e-mail: pr@arterium.ua
mob.: +38093 124 87 26